Lupin Lyfe Platform Secures Class C Medical Device License from CDSCO
Lupin Digital Health has announced that its Lyfe platform has received approval as a Class C Medical Device from the Central Drugs Standard Control Organization (CDSCO).
Cardiologists | 25/04/2024 | By Aishwarya | 189
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy